Cargando…

Biopolymer-Based Nanosystems for siRNA Drug Delivery to Solid Tumors including Breast Cancer

Nanobiopolymers such as chitosan, gelatin, hyaluronic acid, polyglutamic acid, lipids, peptides, exosomes, etc., delivery systems have prospects to help overwhelmed physiological difficulties allied with the delivery of siRNA drugs to solid tumors, including breast cancer cells. Nanobiopolymers have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Subhan, Md Abdus, Torchilin, Vladimir P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861964/ https://www.ncbi.nlm.nih.gov/pubmed/36678782 http://dx.doi.org/10.3390/pharmaceutics15010153

Ejemplares similares

Advances with Lipid-Based Nanosystems for siRNA Delivery to Breast Cancers
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Dendrimers for siRNA Delivery
por: Biswas, Swati, et al.
Publicado: (2013)

Multifunctional polymeric micelles for delivery of drugs and siRNA
por: Jhaveri, Aditi M., et al.
Publicado: (2014)

Advances in Targeted Therapy of Breast Cancer with Antibody-Drug Conjugate
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Biopolymer-Based Nanosystems: Potential Novel Carriers for Kidney Drug Delivery
por: Li, Hao, et al.
Publicado: (2023)

Approaches to Improve EPR-Based Drug Delivery for Cancer Therapy and Diagnosis
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Barriers to drug delivery in solid tumors
por: Sriraman, Shravan Kumar, et al.
Publicado: (2014)

Delivery of Therapeutic Biopolymers Employing Silica-Based Nanosystems
por: Gándara, Zoila, et al.
Publicado: (2023)

Multifunctional nanosystems: growing sanguinity in siRNA therapy
por: Badrealam, Khan Farheen, et al.
Publicado: (2014)

Recent Advances with Precision Medicine Treatment for Breast Cancer including Triple-Negative Sub-Type
por: Subhan, Md Abdus, et al.
Publicado: (2023)

Activatable “Matryoshka” nanosystem delivery NgBR siRNA and control drug release for stepwise therapy and evaluate drug resistance cancer
por: Xu, Xinzhi, et al.
Publicado: (2022)

Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multi-drug resistant tumors
por: Essex, Sean, et al.
Publicado: (2014)

Innovative Delivery of siRNA to Solid Tumors by Super Carbonate Apatite
por: Wu, Xin, et al.
Publicado: (2015)

Drug Delivery of siRNA Therapeutics
por: Lamberti, Gaetano, et al.
Publicado: (2020)

Recent Advances in Tumor Targeting via EPR Effect for Cancer Treatment
por: Subhan, Md Abdus, et al.
Publicado: (2021)

Co-Delivery of siRNA and Chemotherapeutic Drug Using 2C5 Antibody-Targeted Dendrimer-Based Mixed Micelles for Multidrug Resistant Cancers
por: Yalamarty, Satya Siva Kishan, et al.
Publicado: (2022)

Surface-engineered polyethyleneimine-modified liposomes as novel carrier of siRNA and chemotherapeutics for combination treatment of drug-resistant cancers
por: Mendes, Livia P., et al.
Publicado: (2019)

Microfluidic-Based Cationic Cholesterol Lipid siRNA Delivery Nanosystem: Highly Efficient In Vitro Gene Silencing and the Intracellular Behavior
por: Zhu, Zhaoyuan, et al.
Publicado: (2022)

Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy
por: Ahmed, Muneeb, et al.
Publicado: (2015)

siRNA-containing liposomes modified with polyarginine effectively silence the targeted gene
por: Zhang, Chunling, et al.
Publicado: (2006)

Solid polymeric microparticles enhance the delivery of siRNA to macrophages in vivo
por: Lee, Sungmun, et al.
Publicado: (2009)

Using drug-excipient interactions for siRNA delivery()
por: Bruno, Katharina
Publicado: (2011)

Hydrogel-Based Drug Delivery Nanosystems for the Treatment of Brain Tumors
por: Basso, João, et al.
Publicado: (2018)

Targeted Delivery of siRNA Therapeutics to Malignant Tumors
por: Leng, Qixin, et al.
Publicado: (2017)

Targeted Delivery of siRNA
por: Oliveira, Sabrina, et al.
Publicado: (2006)

Nanosystems for the Encapsulation of Natural Products: The Case of Chitosan Biopolymer as a Matrix
por: Detsi, Anastasia, et al.
Publicado: (2020)

A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids
por: Wen, Jiaolin, et al.
Publicado: (2021)

Multi-Functional Nanogels for Tumor Targeting and Redox-Sensitive Drug and siRNA Delivery
por: Adamo, Giorgia, et al.
Publicado: (2016)

The Potential of Drug Delivery Nanosystems for Sepsis Treatment
por: Shi, Yi, et al.
Publicado: (2021)

Aptamer mediated siRNA delivery
por: Chu, Ted C., et al.
Publicado: (2006)

Pulmonary delivery of therapeutic siRNA
por: Lam, Jenny Ka-Wing, et al.
Publicado: (2012)

Intranasal Delivery of Antiviral siRNA
por: Barik, Sailen
Publicado: (2010)

In Vivo Follow-Up of Gene Inhibition in Solid Tumors Using Peptide-Based Nanoparticles for siRNA Delivery
por: Ferreiro, Isabel, et al.
Publicado: (2021)

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
por: Juliano, Rudy, et al.
Publicado: (2008)

Where should siRNAs go: applicable organs for siRNA drugs
por: Ahn, Insook, et al.
Publicado: (2023)

Tumor-Microenvironment- Responsive Size-Shrinkable Drug-Delivery Nanosystems for Deepened Penetration Into Tumors
por: Cheng, Xiaoliang, et al.
Publicado: (2020)

Polyphosphoester nanoparticles as biodegradable platform for delivery of multiple drugs and siRNA
por: Elzeny, Hadeel, et al.
Publicado: (2017)

Harnessing in vivo siRNA delivery for drug discovery and therapeutic development
por: Xie, Frank Y., et al.
Publicado: (2006)

Hydrogels and Their Applications in Targeted Drug Delivery
por: Narayanaswamy, Radhika, et al.
Publicado: (2019)

Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
por: Kim, Jung Seok, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cid8hd61vfbg6vnk65pgm09qim